Filing Analysis
SWK Holdings Corp (SWKH) completed its merger with Runway Growth Finance Corp (RWAY) on April 6, 2026, becoming a wholly-owned subsidiary. As a result, SWKH common stock is being delisted from Nasdaq and all previous management and directors have been replaced.
🚩 Red Flags
- Delisting of common stock from Nasdaq and suspension of reporting obligations.
- Complete turnover of the Board of Directors and executive leadership.
- Change in control resulting in the company becoming a subsidiary of RWAY.
📋 Key Facts
- Merger consideration per share: Choice of 1.7264 RWAY shares or $20.59 in cash, plus a $0.74 guaranteed cash payment.
- Total consideration paid: $173,539,245.32 in cash and approximately 6,330,640 RWAY shares.
- SWKH common stock trading was suspended on Nasdaq effective April 6, 2026.
- First Horizon Bank credit facility was terminated and all outstanding obligations were paid in full.
- 9.00% Senior Notes due 2027 (SWKHL) remain outstanding with a Second Supplemental Indenture to comply with the Investment Company Act of 1940.
SWK Holdings Corporation stockholders overwhelmingly approved a merger agreement with Runway Growth Finance Corp. (RWAY) at a special meeting held on March 31, 2026. The approval marks a definitive step toward the company being acquired and becoming a wholly-owned subsidiary of RWAY.
🚩 Red Flags
- The company will cease to exist as an independent entity upon the closing of the merger.
- Approval of 'golden parachute' compensation for named executive officers and directors in connection with the merger.
📋 Key Facts
- The special meeting was held on March 31, 2026, with 93.06% of the 12,095,906 outstanding shares represented.
- Proposal 1 (Merger Agreement) was approved with 11,240,819 votes in favor and only 8,763 against.
- The merger agreement was originally dated October 9, 2025, involving Runway Growth Finance Corp. and its subsidiaries.
- Stockholders also approved non-binding advisory proposals regarding executive and director compensation related to the merger.
- SWK Holdings will merge into Acquisition Sub, a subsidiary of RWAY, with Acquisition Sub as the surviving entity.
SWK Holdings Corp entered into a Seventh Amendment to its Credit Agreement on February 12, 2026. The amendment results in a reduction of aggregate credit commitments from $10.0 million to $7.5 million and modifies existing financial covenants.
🚩 Red Flags
- Reduction in available credit facility ($2.5M decrease) suggests tightening liquidity or reduced lender confidence
- Modification of financial covenants often indicates the company was at risk of breaching existing terms
- Micro-cap context: A reduction in total debt capacity/liquidity can be critical for operational runway
📋 Key Facts
- Amendment effective date: February 12, 2026
- Aggregate commitments reduced from $10.0 million to $7.5 million
- The amendment includes modifications to financial covenants
- Parties involved include SWK Holdings Corp, SWK Funding LLC, and First Horizon Bank as lender/agent
SWK Holdings Corp has entered into a Sixth Amendment to its Credit Agreement that significantly reduces its aggregate credit commitments from $60.0 million down to $10.0 million, effective December 4, 2025.
🚩 Red Flags
- Significant reduction in liquidity/credit facilities (from $60M to $10M) suggests potential tightening of capital access or lender concerns regarding the company's ability to repay.
- The massive scale of the commitment reduction is a strong indicator of credit risk for a micro-cap entity.
📋 Key Facts
- The amendment was executed on December 4, 2025, involving SWK Holdings Corp, SWK Funding LLC, and First Horizon Bank.
- Aggregate commitments under the Credit Agreement were reduced from $60.0 million to $10.0 million.
- The original Credit Agreement is dated June 28, 2023.
- This represents a $50.0 million reduction in available credit capacity.
SWK Holdings Corp announced that the FTC has granted early termination of the waiting period for its merger with Runway Growth Finance Corp. The transaction is expected to close in Q1 2026, pending stockholder approval.
🚩 Red Flags
- Transaction remains subject to stockholder approval, which introduces execution risk.
📋 Key Facts
- Merger agreement originally entered into on October 9, 2025, with Runway Growth Finance Corp (Parent).
- The Bureau of Competition of the U.S. FTC granted early termination of the HSR waiting period on December 2, 2025.
- Transaction involves a series of mergers where SWK Holdings will merge into Parent.
- Closing is expected to occur in the first quarter of 2026.
- Final consummation is subject to stockholder approval and other customary closing conditions.
SWK Holdings Corp announced its third quarter 2025 financial results via a press release. The filing is a standard earnings announcement containing no material changes to corporate structure or significant unexpected events.
📋 Key Facts
- Reporting period: Third Quarter 2025
- Report Date: November 6, 2025
- The company released financial results via Exhibit 99.1.
SWK Holdings Corp entered into a definitive Merger Agreement with Runway Growth Finance Corp. and its subsidiaries, which will result in SWKH becoming a wholly owned subsidiary of Parent through a multi-step merger process.
🚩 Red Flags
- Complexity of the merger structure (three distinct merger steps) can introduce execution risk.
- Valuation uncertainty: The final per-share consideration is heavily dependent on the 'Adjudicated Portfolio Value' and NAV calculations determined by a third-party valuation firm.
📋 Key Facts
- Merger Agreement signed on October 9, 2025, with Runway Growth Finance Corp. (Parent).
- The transaction involves a three-step merger structure involving Acquisition Sub and Intermediary Sub.
- Consideration for shareholders includes an election between cash (based on Company Net Asset Value) or Parent Common Stock (based on NAV ratio), plus a guaranteed cash payment of approximately $0.74 per share from the Parent External Adviser.
- The deal is subject to customary closing conditions including stockholder approval and regulatory/antitrust clearances.
- Includes 'no-shop' provisions preventing SWKH from soliciting competing proposals.
SWK Holdings Corporation has entered into a definitive merger agreement with Runway Growth Finance Corp. Under the terms of the agreement, SWKH will become a wholly-owned subsidiary of Runway Growth Finance Corp. through a multi-step merger process.
🚩 Red Flags
- Potential for significant management distraction during the merger process.
- Risk of stockholder litigation regarding the merger terms.
- Uncertainty regarding the ability to realize anticipated synergies and cost savings.
📋 Key Facts
- Definitive merger agreement signed on October 9, 2025.
- Counterparty: Runway Growth Finance Corp. (Parent).
- Structure involves a three-step merger involving RWAY Portfolio Corp. and Intermediary Sub.
- The transaction will result in SWKH becoming a wholly-owned subsidiary of Parent.
- Transaction requires stockholder approval from the Company.
SWK Holdings Corporation announced the full repayment of its loan to Elutia, Inc. following Elutia's sale of its BioEnvelope business to Boston Scientific for $88 million. The payoff resulted in a gain for SWKH, exceeding the net GAAP carrying value by approximately $3.9 million.
📋 Key Facts
- Full repayment received from Elutia, Inc. on October 1, 2025.
- Total payoff amount: $27.8 million (includes principal, exit fees, and accrued interest).
- Net GAAP carrying value of the loan as of June 30, 2025, was $23.9 million.
- Expected incremental income: ~$1.4 million from accelerated exit fee recognition and ~$1.4 million from release of loan loss reserves.
- The payoff was triggered by Elutia's sale of BioEnvelope to Boston Scientific Corporation for $88 million in cash.
SWK Holdings Corporation filed an 8-K to report its second quarter 2025 financial results and provide an updated investor presentation. The filing includes non-GAAP financial measures reconciled to GAAP figures.
📋 Key Facts
- Reporting of 2025 Second Quarter Financial Results (Item 2.02).
- Release of a new Investor Presentation (Exhibit 99.2) effective August 2025.
- Disclosure of non-GAAP financial measures and their reconciliation to GAAP results.
SWK Holdings Corporation has completed the sale of substantially all assets related to its MOD3 Pharma Inc. contract manufacturing and development services business to AptarGroup, Inc. for an aggregate purchase price of approximately $6.9 million.
🚩 Red Flags
- Divestiture of a core business segment (contract manufacturing/formulation services) may indicate a shift in corporate strategy or liquidity needs.
- The relatively small transaction value ($6.9M) suggests this is a significant divestiture for a micro-cap company, potentially impacting future revenue streams.
📋 Key Facts
- The transaction involves the sale of assets from MOD3 Pharma Inc. (a wholly owned subsidiary) to AptarGroup, Inc.
- Aggregate purchase price is approximately $6.9 million.
- The price includes cash previously paid under an exclusive option agreement dated March 19, 2024.
- Transaction completed on July 15, 2025.
- A portion of the purchase price is subject to holdbacks for indemnification obligations.
SWK Holdings Corp reported the results of its 2025 Annual Meeting of Stockholders held on June 13, 2025. The meeting included the election of three directors and approval of several shareholder proposals, including an amendment to the company's equity incentive plan.
🚩 Red Flags
- Significant 'Against' vote on the Equity Incentive Plan amendment (approx. 10.8% of voting shares), suggesting potential shareholder dissatisfaction with compensation structures or dilution concerns.
📋 Key Facts
- Annual Meeting held virtually on June 13, 2025.
- Jerry Albright, Laurie L. Dotter, and Robert K. Hatcher were elected to the Board of Directors until the 2026 Annual Meeting.
- Stockholders approved an amendment to the 2010 Equity Incentive Plan to extend its termination date to June 13, 2030.
- BPM LLP was ratified as the independent registered public accounting firm for fiscal year 2025.
- Shareholders approved executive compensation on an advisory basis (Say-on-Pay).
- The Plan Amendment regarding equity incentives received significant opposition, with 1,163,714 votes against compared to 9,696,192 in favor.
SWK Holdings Corporation has authorized a share repurchase program of up to $10.0 million. The program is scheduled to run from May 19, 2025, through May 19, 2026.
📋 Key Facts
- Authorization for the Board of Directors to repurchase up to $10.0 million in common stock.
- Repurchase period: May 19, 2025, to May 19, 2026.
- Repurchases will be conducted via a trading plan complying with Rule 10b5-1 and Rule 10b-18.
- The Board retains the discretion to suspend or discontinue the program at any time.
SWK Holdings Corp. filed an 8-K to disclose the publication of a new investor presentation containing Non-GAAP financial measures. The filing is primarily intended to satisfy Regulation FD requirements regarding the dissemination of information to investors.
📋 Key Facts
- The company published an investor presentation slideshow on May 15, 2025.
- The presentation includes Non-GAAP Financial Measures and reconciliations to GAAP net income and net cash provided by operating activities.
- The disclosure is intended for use in presentations to investors and other parties.
SWK Holdings Corp announced its first quarter 2025 financial results via an 8-K filing. The filing includes a press release detailing the company's operational and financial performance for the period.
📋 Key Facts
- Reporting of 2025 First Quarter Financial Results.
- Filing date: May 15, 2025.
- The report is accompanied by a press release (Exhibit 99.1).
- Company identifies as an 'Emerging Growth Company' under SEC rules.
SWK Holdings Corp completed the sale of its majority royalty portfolio to SCOF SPV I, LP for approximately $34.0 million in cash. Following this asset disposition, the company declared a significant cash dividend of $4.00 per share.
🚩 Red Flags
- Significant asset disposition (royalty portfolio) which may impact long-term recurring revenue streams.
- Large cash dividend relative to transaction size suggests a potential liquidation or capital return event rather than reinvestment in growth.
📋 Key Facts
- Completed the 'Royalty Sale' on April 10, 2025.
- Sale price: approximately $34.0 million in cash and assumption of related liabilities.
- Purchaser is SCOF SPV I, LP (affiliated with Soleus Capital Management L.P.).
- The sale involves rights to receive royalties under contracts held by SWK Funding LLC.
- Board declared a cash dividend of $4.00 per share of common stock.
- Dividend record date: April 24, 2025; Payment date: May 8, 2025.
SWK Holdings Corp entered into a definitive agreement to sell its performing royalty portfolio to SCOF SPV I, L.P. for approximately $34.0 million. The company also reported the successful exercise of a buy-back option by ANI Pharmaceuticals, resulting in $17.3 million in gross proceeds.
🚩 Red Flags
- Asset monetization: The company is selling off its primary income-generating assets (royalty portfolio) to raise cash, which may impact long-term recurring revenue streams.
📋 Key Facts
- Entered into a Purchase and Sale Agreement with SCOF SPV I, L.P. on March 19, 2025.
- The 'Royalty Sale' involves the assignment of rights to receive royalties from the Company's performing royalty portfolio.
- Aggregate purchase price for the Royalty Sale is approximately $34.0 million.
- Company intends to use a portion of the proceeds to declare a cash dividend to stockholders.
- ANI Pharmaceuticals, Inc. exercised a buy-back option on March 17, 2025, regarding royalties for ILUVIEN® and YUTIQ® products.
- The ANI Royalty Buy-Out generated approximately $17.3 million in gross proceeds.
SWK Holdings Corp filed an 8-K to disclose the publication of a new investor presentation containing non-GAAP financial measures. This is a routine regulatory disclosure used for investor relations and Regulation FD compliance.
📋 Key Facts
- Company published an updated Investor Presentation on March 20, 2025.
- The presentation includes Non-GAAP Financial Measures reconciled to GAAP results.
- The filing serves to satisfy Regulation FD disclosure requirements.
SWK Holdings Corp (SWKH) filed an 8-K to report its 2024 Fourth Quarter Financial Results. The filing contains a press release detailing the company's recent operational and financial performance.
📋 Key Facts
- Reporting period: 2024 Fourth Quarter Financial Results
- Filing date: March 20, 2025
- The report includes an exhibit (99.1) containing the press release of results.
SWK Holdings Corp filed an 8-K to disclose the publication of a new investor presentation containing Non-GAAP financial measures. The filing is primarily a regulatory requirement under Regulation FD to ensure all investors have access to the same information.
📋 Key Facts
- The company published an Investor Presentation on November 15, 2024 (Exhibit 99.1).
- The presentation includes Non-GAAP financial measures and reconciliations to GAAP results.
- Management intends to use the presentation for investor relations and shareholder value assessment.
SWK Holdings Corp announced its third quarter 2024 financial results via an 8-K filing. The filing serves as a formal announcement of the company's quarterly performance and includes a corresponding press release.
📋 Key Facts
- Reported date: November 14, 2024
- Reporting period: Third Quarter 2024 Financial Results
- The filing includes an exhibit (99.1) containing the official press release regarding quarterly performance.
- Company is listed on Nasdaq under ticker SWKH.
SWK Holdings Corporation announced the resignation of Marcus Pennington from its Board of Directors, effective October 1, 2024. The company stated the departure was not due to any disagreements regarding operations, policies, or practices.
🚩 Red Flags
- None identified in this specific filing; resignation is characterized as non-dispute related.
📋 Key Facts
- Marcus Pennington resigned from the Board of Directors on September 30, 2024.
- The resignation became effective October 1, 2024.
- The company stated there were no disagreements with the Company regarding operations, policies, or practices.
- The Nominating and Corporate Governance Committee will initiate a search for a replacement.
SWK Holdings Corp filed an 8-K to provide a Regulation FD disclosure via an investor presentation slideshow. The filing includes non-GAAP financial measures intended for use in upcoming presentations to investors.
📋 Key Facts
- Filed on August 15, 2024.
- Includes an Investor Presentation (Exhibit 99.1) containing non-GAAP financial measures.
- The presentation is intended for use with investors and other parties.
- Company provides reconciliations of non-GAAP measures to GAAP results within the presentation.
SWK Holdings Corp announced its second quarter 2024 financial results via a press release. The filing serves as the formal mechanism to disclose quarterly performance metrics and operational updates.
📋 Key Facts
- Reporting period: Second Quarter 2024
- Filing date: August 15, 2024
- The company released financial results via Exhibit 99.1
- Signatories include CEO Joe D. Staggs and CFO Adam Rice
SWK Holdings Corporation issued an 8-K to furnish a corporate update regarding its portfolio companies as of July 17, 2024. The filing serves primarily as a vehicle to distribute a press release containing operational updates.
📋 Key Facts
- The company released a 2024 corporate update on July 17, 2024.
- The update pertains to the performance and status of the company's portfolio companies.
- The information was provided via Exhibit 99.1 and is not considered 'filed' for purposes of Section 18 of the Exchange Act.
SWK Holdings Corp announced the appointment of Adam Rice as Chief Financial Officer, effective July 3, 2024. Mr. Rice will also serve as the company's principal financial and accounting officer.
📋 Key Facts
- Adam Rice appointed CFO, Principal Financial Officer, and Principal Accounting Officer effective July 3, 2024.
- Annual base salary for the new CFO is $302,500.
- Incentive cash bonus target is set at 60% of annual base salary.
- Grant of restricted stock valued at $100,000 as of July 3, 2024, vesting over four years (25% annually).
- Mr. Rice previously served as a fractional CFO consultant and held senior finance roles at Park Cities Asset Management and Mr. Cooper Group Inc.
SWK Holdings Corporation reported the results of its 2024 Annual Meeting of Stockholders held on June 14, 2024. The meeting included the election of four directors and the ratification of auditors.
📋 Key Facts
- The 2024 Annual Meeting was held virtually on June 14, 2024.
- Jerry Albright, Laurie L. Dotter, Robert K. Hatcher, and Marcus Pennington were elected to the Board of Directors by a plurality of votes.
- BPM LLP was ratified as the Company's independent registered public accounting firm for the 2024 fiscal year.
- Stockholders approved executive compensation on an advisory basis.
SWK Holdings Corporation announced a new share repurchase program and released an updated investor presentation. The company has authorized the Board to repurchase up to $10.0 million of common stock over the next year.
📋 Key Facts
- Board authorized a repurchase of up to $10.0 million in outstanding common stock.
- Repurchase program timeframe: May 16, 2024, through May 16, 2025.
- Repurchases will be conducted via a trading plan complying with Rule 10b5-1 and Rule 10b-18.
- Company released an updated Investor Presentation (Exhibit 99.1) on May 17, 2024.
SWK Holdings Corporation filed an 8-K to report its financial results for the first quarter of 2024. The filing serves as a formal announcement of quarterly performance via an attached press release.
📋 Key Facts
- Reporting period: First Quarter 2024
- Filing date: May 15, 2024
- The company released financial results via Exhibit 99.1 (Press Release).
- Ticker symbol: SWKH; Exchange: Nasdaq.
SWK Holdings Corp filed an 8-K to disclose the publication of a new investor presentation containing Non-GAAP financial measures. The filing is primarily for Regulation FD compliance and does not contain material changes to operations, capital structure, or governance.
📋 Key Facts
- Company published an updated Investor Presentation on March 22, 2024 (Exhibit 99.1).
- The presentation includes Non-GAAP financial measures intended to provide additional insight into business operations and shareholder value.
- The company provided reconciliations of Non-GAAP measures to the most comparable GAAP financial measures as required by Regulation G.
SWK Holdings Corporation filed an 8-K to report its financial results for the fourth quarter of fiscal year 2023. The filing includes a press release detailing the company's recent operational and financial performance.
📋 Key Facts
- Reporting period: Fourth Quarter 2023
- Filing date: March 21, 2024
- The report contains results of operations and financial condition via Exhibit 99.1.
SWK Holdings Corp (via its subsidiary Enteris Biopharma) has entered into an exclusive option and asset purchase agreement with AptarGroup, Inc. for the sale of its GMP manufacturing and clinical supply services business assets.
🚩 Red Flags
- Asset disposition of a core business segment (GMP manufacturing/clinical supply) may impact long-term revenue streams.
- The relatively low asset price (~$6M + inventory) suggests the divested assets may be non-core or currently underperforming.
📋 Key Facts
- Agreement date: March 13, 2024; Filing date: March 19, 2024.
- AptarGroup holds an exclusive option to acquire Enteris's GMP manufacturing and clinical supply services business assets through January 1, 2026.
- Aptar will pay a 'low-single digit million dollar' option fee in two installments (first portion upon execution; second by Jan 1, 2025).
- If exercised, the Asset Price is approximately $6 million plus inventory and prepaid expenses, with a high single-digit annual growth rate adjustment if not exercised within six months.
- Aptar will guarantee minimum annual revenue payments in the 'mid-single digit million dollar' range for 2024 and 2025 under existing collaboration agreements.
SWK Holdings Corp announced the resignation of its CFO, Yvette Heinrichson, effective February 13, 2024. The CEO will assume interim responsibilities for the financial and accounting functions while a search for a successor is conducted.
🚩 Red Flags
- CEO assuming dual roles (CEO and interim CFO) can create operational strain and concentration of control.
- Sudden departure of a CFO, even if stated as non-dispute related, often requires close monitoring of subsequent financial filings for transition issues.
📋 Key Facts
- CFO Yvette Heinrichson resigned on January 30, 2024, effective February 13, 2024.
- The resignation was not due to any disagreement with the Company or its independent auditors regarding financial/accounting operations.
- CEO Joe D. Staggs will serve as interim principal financial and accounting officer.
- Ms. Heinrichson will enter a consulting agreement to assist with the transition through the filing of the Q1 2024 Form 10-Q.